Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwabe Extracta is the specialized manufacturing and extraction division of the Schwabe Group, a global leader in the field of phytopharmaceuticals. The company is dedicated to the development and large-scale production of high-quality, standardized herbal extracts that serve as active pharmaceutical ingredients (APIs). Utilizing advanced Phytoneering technology, Schwabe Extracta ensures that its natural products meet rigorous pharmaceutical standards for efficacy, safety, and consistency. Their portfolio includes world-renowned extracts such as EGb 761 for cognitive health and EPs 7630 for respiratory infections. Based in Karlsruhe, Germany, the company operates state-of-the-art GMP facilities and manages a complex global supply chain for medicinal plants. Schwabe Extracta supports both the internal needs of the Schwabe Group and provides specialized extraction services to international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwabe Extracta.